Fresenius (NYSE:FMS) shares are down roughly 10% today after the German dialysis giant softened its outlook. “Given its current expectations for 2018 and 2019, Fresenius now believes its ambitious group targets for 2020 will not be met,” Fresenius said. Overall earnings next year are now expected to be flat on mid-single-digit sales growth, compared with prior […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Report: US healthcare spending growth slows to 3.9%
National healthcare spending grew 3.9% last year to approximately $3.5 trillion, or $10,739 per person, according to a report from The Hill using data recently released by the Trump administration. The growth is the slowest increase in healthcare spending since 2013, before many parts of the ACA took effect, according to the report. Growth rates […]
Globus Medical launches ExcelsiusGPS in EU
Globus Medical (NYSE:GMED) said yesterday that it launched its ExcelsiusGPS robotic guidance and navigation system in the global market, having completed installations of the system in several European countries. The ExcelsiusGPS system won CE Mark clearance in the EU in early 2017 with indications for use in both minimally invasive and open procedures for orthopedics and […]
Bruin Biometrics lands second SBIR award for ortho device
Bruin Biometrics (BBI) said it has won a $1.4 million Small Business Innovation Research (SBIR) Phase II program award from The National Institute of Arthritis and the musculoskeletal and skin division of the National Institutes of Health. BBI (Los Angeles) uses biometric sensor technology to aid clinicians in the early detection and monitoring of chronic, […]
How Reggie Groves reinvented Medtronic’s atrial fibrillation biz
Reva Medical (ASX:RVA) CEO Reggie Groves got her start in the medical device industry at medtech titan Medtronic. In her upcoming keynote interview at DeviceTalks West, Groves will discuss how that experience has shaped her as a leader and an innovator. Here’s a preview: When Reggie Groves joined Medtronic (NYSE:MDT) in 2002, she didn’t know very much […]
What is the future of medtech in 2019?
A global push to increase medical device industry regulation and the continued blurring of high tech and medtech – those are but some of the predictions that Medical Design & Outsourcing editors are hearing from experts. Read on to discover some of the top predictions of where the industry is going in 2019. Next>> Senior […]
Imaging dev Lightpoint Medical raises $6m
Medical imaging dev Lightpoint Medical said today it raised approximately $6.4 million (GBP £5 million) in a new financing round slated to support the commercialization of the company’s robotic laparoscopic probe and its LightPath imaging system. Money in the round came from Cambridge Capital Group, Venture Founders, Coutts Investment Club, Envestors, Fund Twenty8, SyndicateRoom and […]
Vapotherm touts automated oxygen controller in preemie study
A recent clinical trial showed that Vapotherm’s (NYSE: VAPO) new IntellO2 module for its Precision Flow system greatly improved the chances of keeping premature babies in the target oxygenation range. The prospective, multi-center, controlled, order-randomized crossover trial demonstrated that using the IntellO2 module helped clinicians maintain newborns in the physician-prescribed oxygen saturation range 80% of the time, compared with 49 % […]
Ex-biotech investing legend Burrill sentenced to 30 months for fraud, tax evasion
Well-known biotech investor G. Steven Burrill has been sentenced to 30 months in federal prison on charges of fraud and tax evasion, according to an Xconomy report. Burrill faced accusations of diverting more than $18 million from the $283 million Burrill Life Sciences Capital Fund III between 2007 and 2013 under the cover of management […]
Impel NeuroPharma raises $68m for CNS drug-device tech
Impel NeuroPharma said today that it raised $67.5 million in a Series D financing round, with investments from KKR, Norwest Venture Partners, Vivo Capital, 5Am Ventures and venBio Partners. The Seattle-based company plans to use the round’s proceeds to support clinical development efforts for its intranasal drug-delivery device technology. Get the full story at our sister site, […]
Novocure touts analysis of pivotal glioblastoma trial results
Novocure (NSDQ:NVCR) today touted the results of a retrospective sub-group analysis of its EF-14 Phase III pivotal trial in patients with newly diagnosed glioblastoma. The analysis, which was published in the Journal of Neuro-Oncology, demonstrated that more time on Novocure’s Optune device predicted increased survival in people who received Optune plus temozolomide compared to those who received […]